 compared
with RFA at one month (SMD, e0.03; 95% CI, e0.66 to
0.59; I2 Â¼ 77.8%; 2 studies40,58).
Recurrent varicosity. HL/S was associated with a lower
risk of recurrent varicosity compared with UGFS (RR, 0.24;
95% CI, 0.07-